# Alkermes (ALKS) — Overview

ALKS · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/alks

## Price

Last close $39.62 on Oct 15, 2026. 52-week range $27.20 – $55.22.

## Company profile

Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.

## Financials

| Metric | Value |
| --- | --- |
| Revenue (trailing twelve months) | $1.7B |
| Revenue (quarter) | $496.0M |
| Revenue growth (year over year) | 26.97% |
| Gross profit (trailing twelve months) | $1.4B |
| Gross margin | 84.56% |
| Net income (trailing twelve months) | $66.1M |
| Net income (quarter) | $501,000.00 |
| Net income growth (year over year) | -99.42% |
| Net margin | 3.97% |
| Return on equity | 3.85% |
| EPS (trailing twelve months) | $0.40 |
| Book value per share | $10.79 |
| P/E (trailing twelve months) | 100.1 |
| Price to book | 3.7 |
| Debt to assets | 58.83% |
| Payout ratio | 0.00% |
| Dividend yield | 0.00% |

## Frequently Asked Questions

### Is Alkermes (ALKS) profitable?

Yes. Alkermes earned $66.1M in net income over the trailing twelve months, a net margin of 3.97%.

### How much revenue does Alkermes (ALKS) make?

Alkermes generated $1.7B in revenue over the trailing twelve months, up 26.97% year over year.

### What is ALKS's P/E ratio?

Alkermes trades at 100.1 times trailing twelve-month earnings, on an EPS of $0.40.

### How do I buy stock in Alkermes (ALKS)?

ALKS trades commission-free with a Light Horse Securities brokerage account — from the mobile app, the web at [Light Horse Dashboard](https://portal.lighthorse.io), the trading API, or an [AI agent connected over MCP](/instructions/ai/claude). The trade panel on this page places the order once you are signed in.

## Similar Stocks

- [MEDP](https://www.lighthorse.io/tickers/medp) — Medpace Holdings, Inc. - Common Stock
- [AMN](https://www.lighthorse.io/tickers/amn) — AMN Healthcare Services Inc
- [OMCL](https://www.lighthorse.io/tickers/omcl) — Omnicell, Inc. - Common Stock
- [ABEO](https://www.lighthorse.io/tickers/abeo) — Abeona Therapeutics Inc. - Common Stock

---

Quotes and charts are not real-time and must not be relied on for trade decisions or valuation.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).